[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2022 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -35.56%
YoY- 19.87%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 3,510,677 3,530,609 3,446,552 3,848,696 4,815,015 5,471,062 3,941,244 -7.40%
PBT -580,846 76,732 83,920 149,756 277,075 202,649 107,536 -
Tax -24,204 -24,536 -24,380 -34,332 -104,870 -86,596 -34,104 -20.38%
NP -605,050 52,196 59,540 115,424 172,205 116,053 73,432 -
-
NP to SH -607,317 49,430 56,912 110,936 172,150 115,566 73,680 -
-
Tax Rate - 31.98% 29.05% 22.93% 37.85% 42.73% 31.71% -
Total Cost 4,115,727 3,478,413 3,387,012 3,733,272 4,642,810 5,355,009 3,867,812 4.21%
-
Net Worth -248,894 411,327 406,087 413,947 450,411 391,428 357,275 -
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 24,889 33,185 34,058 41,918 121,768 75,056 60,200 -44.41%
Div Payout % 0.00% 67.14% 59.84% 37.79% 70.73% 64.95% 81.71% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth -248,894 411,327 406,087 413,947 450,411 391,428 357,275 -
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 261,991 191.42%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -17.23% 1.48% 1.73% 3.00% 3.58% 2.12% 1.86% -
ROE 0.00% 12.02% 14.01% 26.80% 38.22% 29.52% 20.62% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 268.00 269.52 263.10 293.80 367.74 417.92 301.16 -7.46%
EPS -46.36 3.77 4.34 8.48 13.15 8.83 5.64 -
DPS 1.90 2.53 2.60 3.20 9.30 5.73 4.60 -44.44%
NAPS -0.19 0.314 0.31 0.316 0.344 0.299 0.273 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 243.59 244.97 239.14 267.04 334.09 379.61 273.46 -7.40%
EPS -42.14 3.43 3.95 7.70 11.94 8.02 5.11 -
DPS 1.73 2.30 2.36 2.91 8.45 5.21 4.18 -44.37%
NAPS -0.1727 0.2854 0.2818 0.2872 0.3125 0.2716 0.2479 -
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 0.545 0.515 0.595 0.755 0.74 0.835 5.29 -
P/RPS 0.20 0.19 0.23 0.26 0.20 0.20 1.76 -76.44%
P/EPS -1.18 13.65 13.70 8.92 5.63 9.46 93.96 -
EY -85.07 7.33 7.30 11.22 17.77 10.57 1.06 -
DY 3.49 4.92 4.37 4.24 12.57 6.87 0.87 151.82%
P/NAPS 0.00 1.64 1.92 2.39 2.15 2.79 19.38 -
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 -
Price 0.44 0.55 0.595 0.72 0.76 0.845 0.925 -
P/RPS 0.16 0.20 0.23 0.25 0.21 0.20 0.31 -35.57%
P/EPS -0.95 14.58 13.70 8.50 5.78 9.57 16.43 -
EY -105.37 6.86 7.30 11.76 17.30 10.45 6.09 -
DY 4.32 4.61 4.37 4.44 12.24 6.79 4.97 -8.89%
P/NAPS 0.00 1.75 1.92 2.28 2.21 2.83 3.39 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment